BB
CELG
BB Biotech’s Celgene Corp CELG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $208M | Sell |
2,200,000
-103,875
| -5% | -$9.8M | 5.22% | 6 |
|
|
2018
Q4 | $148M | Sell |
2,303,875
-680,423
| -23% | -$43.6M | 4.73% | 6 |
|
|
2018
Q3 | $267M | Sell |
2,984,298
-340,000
| -10% | -$30.4M | 7.07% | 3 |
|
|
2018
Q2 | $264M | Hold |
3,324,298
| – | – | 7.62% | 3 |
|
|
2018
Q1 | $297M | Sell |
3,324,298
-100,000
| -3% | -$8.92M | 8.2% | 3 |
|
|
2017
Q4 | $357M | Buy |
3,424,298
+240,000
| +8% | +$25M | 10.06% | 2 |
|
|
2017
Q3 | $464M | Sell |
3,184,298
-65,000
| -2% | -$9.48M | 12.85% | 1 |
|
|
2017
Q2 | $422M | Sell |
3,249,298
-90,000
| -3% | -$11.7M | 12.9% | 2 |
|
|
2017
Q1 | $416M | Sell |
3,339,298
-120,000
| -3% | -$14.9M | 13.59% | 2 |
|
|
2016
Q4 | $400M | Hold |
3,459,298
| – | – | 14.83% | 1 |
|
|
2016
Q3 | $362M | Sell |
3,459,298
-150,000
| -4% | -$15.7M | 12.71% | 2 |
|
|
2016
Q2 | $356M | Hold |
3,609,298
| – | – | 14.05% | 1 |
|
|
2016
Q1 | $361M | Hold |
3,609,298
| – | – | 14.36% | 1 |
|
|
2015
Q4 | $432M | Buy |
3,609,298
+20,000
| +0.6% | +$2.4M | 12.18% | 1 |
|
|
2015
Q3 | $388M | Buy |
3,589,298
+25,000
| +0.7% | +$2.7M | 12.31% | 2 |
|
|
2015
Q2 | $413M | Buy |
3,564,298
+10,000
| +0.3% | +$1.16M | 11.18% | 1 |
|
|
2015
Q1 | $410M | Sell |
3,554,298
-160,000
| -4% | -$18.4M | 12.21% | 1 |
|
|
2014
Q4 | $415M | Sell |
3,714,298
-175,000
| -4% | -$19.6M | 13.46% | 1 |
|
|
2014
Q3 | $369M | Sell |
3,889,298
-330,000
| -8% | -$31.3M | 14.99% | 1 |
|
|
2014
Q2 | $362M | Buy |
4,219,298
+2,034,649
| +93% | +$175M | 17.22% | 1 |
|
|
2014
Q1 | $305M | Buy |
2,184,649
+155,378
| +8% | +$21.7M | 15.72% | 1 |
|
|
2013
Q4 | $343M | Buy |
2,029,271
+30,000
| +2% | +$5.07M | 18.32% | 1 |
|
|
2013
Q3 | $308M | Sell |
1,999,271
-150,915
| -7% | -$23.3M | 16.77% | 1 |
|
|
2013
Q2 | $252M | Buy |
+2,150,186
| New | +$252M | 18.12% | 1 |
|